✉news HealthMedicine first seen 5 h ago, last 29 min ago, peak #28
Obesity expert calls for an end to compounded weight-loss drugs
Original: I’m an obesity expert and can’t wait for the compounding craze to stop
An obesity specialist writing in Fortune argues the compounding craze around weight-loss drugs should stop. Compounded versions of GLP-1 medications like semaglutide spread during shortages of branded drugs such as Wegovy and Ozempic, raising concerns about safety, dosing accuracy and unregulated manufacturing. The expert's comments add a medical voice to a wider debate over access, cost and oversight of copycat injectables as demand for obesity treatment keeps growing.
Why now: Ongoing concern over safety and regulation of compounded GLP-1 weight-loss drugs amid persistent shortages and high demand.
FortuneWegovyOzempicsemaglutide
Rank over time, top of the chart is #1. 4 snapshots from 5 h ago to 29 min ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/866291